The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery—Personal Remarks and Future Prospects
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery—Personal Remarks and Future Prospects
Authors
Keywords
-
Journal
Journal of Personalized Medicine
Volume 11, Issue 3, Pages 229
Publisher
MDPI AG
Online
2021-03-22
DOI
10.3390/jpm11030229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the Cancers
- (2021) Babita Shashni et al. Journal of Personalized Medicine
- Harnessing Extracellular Matrix Biology for Tumor Drug Delivery
- (2021) Nithya Subrahmanyam et al. Journal of Personalized Medicine
- The solid progress of nanomedicine
- (2020) João Pedro Martins et al. Drug Delivery and Translational Research
- Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
- (2020) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Delivering the power of nanomedicine to patients today
- (2020) Matthieu Germain et al. JOURNAL OF CONTROLLED RELEASE
- Tackle the free radicals damage in COVID-19
- (2020) Jun Wu NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Investigating the EPR effect of nanomedicines in human renal tumors via ex vivo perfusion strategy
- (2020) Yuxun Ding et al. Nano Today
- Polymer-conjugated glucosamine complexed with boric acid shows tumor-selective accumulation and simultaneous inhibition of glycolysis
- (2020) Waliul Islam et al. BIOMATERIALS
- Enhancing Tumor Drug Distribution with Ultrasound-Triggered Nanobubbles
- (2019) Pinunta Nittayacharn et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The beginning of the end of the nanomedicine hype
- (2019) Kinam Park JOURNAL OF CONTROLLED RELEASE
- Superior Penetration and Cytotoxicity of HPMA Copolymer Conjugates of Pirarubicin in Tumor Cell Spheroid
- (2019) Hideaki Nakamura et al. MOLECULAR PHARMACEUTICS
- Anti-Tumor Drug-Loaded Oxygen Nanobubbles for the Degradation of HIF-1α and the Upregulation of Reactive Oxygen Species in Tumor Cells
- (2019) Muhammad Saad Khan et al. Cancers
- N -(2-hydroxypropyl)methacrylamide polymer conjugated pyropheophorbide-a, a promising tumor-targeted theranostic probe for photodynamic therapy and imaging
- (2018) Jun Fang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Augmentation of the Enhanced Permeability and Retention Effect with Nitric Oxide-Generating Agents Improves the Therapeutic Effects of Nanomedicines
- (2018) Waliul Islam et al. MOLECULAR CANCER THERAPEUTICS
- Arterial thromboembolic events preceding the diagnosis of cancer in older persons
- (2018) Babak B. Navi et al. BLOOD
- Polymer therapeutics and the EPR effect
- (2017) Hiroshi Maeda JOURNAL OF DRUG TARGETING
- A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy-Problems, Solutions, and Prospects
- (2016) Hiroshi Maeda et al. MICROCIRCULATION
- Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin
- (2016) Hideaki Nakamura et al. MOLECULAR PHARMACEUTICS
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
- (2015) Hiroshi Maeda ADVANCED DRUG DELIVERY REVIEWS
- Styrene-maleic acid-copolymer conjugated zinc protoporphyrin as a candidate drug for tumor-targeted therapy and imaging
- (2015) Jun Fang et al. JOURNAL OF DRUG TARGETING
- HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases
- (2015) Haruhiko Dozono et al. Targeted Oncology
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- The link between infection and cancer: Tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect
- (2013) Hiroshi Maeda CANCER SCIENCE
- Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage
- (2013) Hideaki Nakamura et al. JOURNAL OF CONTROLLED RELEASE
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on D34+/CD38+ and CD34+/CD38- AML Progenitor Cells
- (2012) H. Herrmann et al. CURRENT CANCER DRUG TARGETS
- HSP32 (HO-1) inhibitor, copoly(styrene-maleic acid)-zinc protoporphyrin IX, a water-soluble micelle as anticancer agent: In vitro and in vivo anticancer effect
- (2012) Jun Fang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- PEGylated d-amino acid oxidase restores bactericidal activity of neutrophils in chronic granulomatous disease via hypochlorite
- (2012) Hideaki Nakamura et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Protective Role of d-Amino Acid Oxidase against Staphylococcus aureus Infection
- (2012) Hideaki Nakamura et al. INFECTION AND IMMUNITY
- Drug delivery research in Europe
- (2012) Twan Lammers JOURNAL OF CONTROLLED RELEASE
- Macromolecular therapeutics in cancer treatment: The EPR effect and beyond
- (2012) Hiroshi Maeda JOURNAL OF CONTROLLED RELEASE
- Micelles of zinc protoporphyrin conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer for imaging and light-induced antitumor effects in vivo
- (2012) Hideaki Nakamura et al. JOURNAL OF CONTROLLED RELEASE
- Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting
- (2012) Hiroshi MAEDA PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
- (2010) Hiroshi Maeda BIOCONJUGATE CHEMISTRY
- In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: Survival improvement and inhibition of liver metastases
- (2010) Jurstine Daruwalla et al. CANCER SCIENCE
- Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application
- (2009) Takahiro Seki et al. CANCER SCIENCE
- Elevating Blood Pressure as a Strategy to Increase Tumor-targeted Delivery of Macromolecular Drug SMANCS: Cases of Advanced Solid Tumors
- (2009) Akinori Nagamitsu et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- SMA–copolymer conjugate of AHPP: A polymeric inhibitor of xanthine oxidase with potential antihypertensive effect
- (2009) Jun Fang et al. JOURNAL OF CONTROLLED RELEASE
- Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosis
- (2008) Emir Hadzijusufovic et al. EXPERIMENTAL HEMATOLOGY
- Styrene Maleic Acid-Pirarubicin Disrupts Tumor Microcirculation and Enhances the Permeability of Colorectal Liver Metastases
- (2008) Jurstine Daruwalla et al. JOURNAL OF VASCULAR RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now